Pricing & Market Access Trend Evaluation: Continuously evaluate emerging global market pricing & access dynamics, reimbursement trends, formulary management practices, U.S. PBM/payer coverage tiers, contracting/rebate dynamics, and institutional access pathways to evaluate implications on ROI and refine pricing and access assumptions for pipeline and in-line assets. Legislative Policy Impact Assessment: Assess the impact of evolving global legislative, regulatory, and reimbursement policies-including the U.S. Inflation Reduction Act (IRA), Medicare Best Price rules, European Joint HTA regulations, and other market-specific pricing reforms-on short- and long-term pricing, access, and financial forecasts.